Advertisement
Advertisement
RIGL
Rigel Pharmaceuticals Inc. (New)
39.65
USDSponsored
-6.06
-13.26%
Nov 06, 15:59 UTC -5
Closed
After-Market
39.59
-0.05
-0.14%
Rigel Pharmaceuticals Inc. (New) (RIGL)
Rigel Pharmaceuticals Inc. (New) Financial Snapshot
| Market Cap | 745.57M |
| Beta | 1.28 |
| Earnings Per Share (EPS) | 15.51 |
| Price-to-Book (P/B) Ratio | 1.72 |
| Operating Margin | 21.46% |
| Total Debt/Equity (D/E) | 9.22% |
| P/E Ratio | 12.75 |
| Return on Equity (ROE) | 15.25% |
| Current Ratio | 1.94% |
| Free Cash Flow | 33.38M |
